³×ºæ¶óÀÌÀú ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By Application (COPD, Asthma, Cystic Fibrosis), By End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1679371
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³×ºæ¶óÀÌÀú ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ³×ºæ¶óÀÌÀú ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 17¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦°ÍÀ¸·Î ¿¹ÃøµÇ°í, 2025-2030³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.35%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¸¼º È£Èí±â ÁúȯÀÇ ¹ßº´·ü Áõ°¡, Ȩ ÇコÄÉ¾î ±â±â ¼ö¿ä Áõ°¡, Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

COVID-19´Â Àü ¼¼°è ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. COVID-19ÀÇ °ø±â ÀüÆÄ À§Çè¿¡ ´ëÇØ ¾Ë°í Àִ õ½ÄÀ̳ª COPD ȯÀÚ´Â ¹ÙÀÌ·¯½º ÀüÆÄ ¹× ¸é¿ª ¾ïÁ¦ÀÇ ÀáÀçÀû ¿øÀÎÀ¸·Î °£ÁֵǴ ÈíÀÔ ¾à¹° »ç¿ë¿¡ ´ëÇØ ÁÖÀúÇß½À´Ï´Ù. ÇÏÁö¸¸ ÀÇ·áÁøÀº ¸ðµç ȯÀÚ¿¡°Ô ºÐ¹«±â¸¦ Æ÷ÇÔÇÑ Ã³¹æ¹ÞÀº ÈíÀÔ ¾à¹°À» °è¼Ó »ç¿ëÇϵµ·Ï ±Ç°íÇß½À´Ï´Ù. ¹Ì±¹ ÀϺΠÁö¿ª¿¡¼­´Â ¾à±¹¿¡¼­ ¾ËºÎÅ×·Ñ ÈíÀԱⰡ ºÎÁ·ÇÒ ¶§ ¾ËºÎÅ×·Ñ ±¸Á¶¿ë ÈíÀÔ±âÀÇ ´ë¾ÈÀ¸·Î ºÐ¹«Çü ¾ËºÎÅ×·ÑÀ» ±ÇÀåÇß½À´Ï´Ù.

COVID-19´Â ¸¹Àº ³ëÀο¡°Ô ¿µÇâÀ» ¹ÌĨ´Ï´Ù. 2020³â ¹Ì±¹ÆóÇùȸ(ALA)¿¡ µû¸£¸é ºÐ¹« Ä¡·á´Â Äڷγª19 ȯÀÚ°¡ Áý¿¡¼­ COPD¸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ ¹æ¹ýÀ̶ó°í ÇÕ´Ï´Ù. µû¶ó¼­ ³×ºæ¶óÀÌÀú ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù.

Àα¸ Åë°è±¹ º¸°í¼­ ¡°¹Ì±¹ÀÇ °í·ÉÈ­¡±¿¡ µû¸£¸é ¹Ì±¹ÀÇ ³ëÀÎ Àα¸´Â 2016³â 4,800¸¸ ¸í¿¡¼­ 2060³â 9,800¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎÀº ¸¸¼º Æó¼â¼º ÆóÁúȯÀ̳ª ¼ö¸é ¹«È£ÈíÁõ°ú °°Àº È£Èí±â Áúȯ¿¡ Ãë¾àÇÕ´Ï´Ù. µû¶ó¼­ ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â Á¦Á¶¾÷üÀÇ È¯ÀÚ Ç®À» È®´ëÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Æó¿¡ ¾à¹°À» Á¤È®ÇÏ°Ô Àü´ÞÇϰí ÀÜ·ù·®ÀÌ ÀûÀº ¸Þ½¬ ³×ºæ¶óÀÌÀúÀÇ »ó¾÷Àû ¼ö¿ëÀÌ Áõ°¡ÇÏ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ¾à¹°-±â±â °áÇÕ°ú °°Àº ±â¼ú ¹ßÀüÀº ³×ºæ¶óÀÌÀú ½ÃÀå¿¡¼­ »õ·Î¿î ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ý¸é¿¡ ºÐ¹« Áß ¾à¹° ¼Õ½ÇÀº ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ±×·¯³ª ÀÌ´Â ¾à¹° ¼Õ½ÇÀ» ÁÙÀ̸鼭 Á¤È®ÇÑ ¾à¹° ¿ë·®À» Àü´ÞÇϵµ·Ï ÀåÄ¡°¡ Á¦Á¶µÇ±â ¶§¹®¿¡ ¸Þ½¬ ³×ºæ¶óÀÌÀú Á¦Á¶¾÷ü¿¡°Ô ±âȸ·Î ÀÛ¿ëÇÒ ¼öµµ ÀÖ½À´Ï´Ù.

³×ºæ¶óÀÌÀú ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ³×ºæ¶óÀÌÀú ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ³×ºæ¶óÀÌÀú ½ÃÀå : À¯Çüº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦5Àå ³×ºæ¶óÀÌÀú ½ÃÀå : ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦6Àå ³×ºæ¶óÀÌÀú ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå ³×ºæ¶óÀÌÀú ½ÃÀå : Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Nebulizer Market Growth & Trends:

The global nebulizer market size is estimated to reach USD 1.77 billion by 2030, registering a CAGR of 6.35% from 2025 to 2030, according to a new report by Grand View Research, Inc., Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware regarding the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced shortage of albuterol inhalers.

COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. Consequently, promotes the nebulizers demand.

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

Increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth. Furthermore, Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market.

On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss.

Nebulizer Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Nebulizers Market Variables, Trends & Scope

Chapter 4. Nebulizers Market: Type Estimates & Trend Analysis

Chapter 5. Nebulizers Market: Application Estimates & Trend Analysis

Chapter 6. ebulizers Market: End Use Estimates & Trend Analysis

Chapter 7. Nebulizers Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â